Skip to main content

Table 2 Liver metastases’ characteristic

From: HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study

Characteristic

HIFU (N = 8)

BSC (N = 16)

PC (N = 16)

p value

Previous lines of liver metastases therapy

NA

 Nil

4

16

16

 

 1

3

0

0

 

 2

1

0

0

 

Time from initial diagnosis to HIFU (month), (range)

0–7

–

–

 

Time between last liver-directed therapy and HIFU (month), (range)

0–5

–

–

 

Number

 > 0.1

 1

5

8

8

 

 2

1

4

3

 

 3

2

4

5

 

Maximum size (cm), Median (range)

2.0 (1.2–8.8)

3.8 (1.0–8.0)

3.0 (1.0–7.0)

 > 0.1

Location (liver segment)

NA

 I

0

2

1

 

 II

1

1

3

 

 III

1

1

2

 

 IV

1

5

1

 

 V

1

3

4

 

 VI

4

7

6

 

 VII

1

1

3

 

 VIII

2

2

4

 

Systematic treatment after HIFU

 

 No

1

–

–

 

 Yes

7

–

–

 

Input energy of HIFU (kJ), Median(IQR)

625 (353–848)

–

–

 

Input power of HIFU (W), Median(IQR)

340 (297–360)

–

–

 

Cumulative transmit time of HIFU (s), Median(IQR)

1890 (1230–2219)

–

–

 
  1. HIFU high intensity focused ultrasound, BSC best supportive care, PC palliative chemotherapy, NA not available